다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

SNGX

Soligenix (SNGX)

Soligenix Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SNGX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/25	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNGX	Soligenix Inc
2024/05/24	20:30	PR Newswire (US)	Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting	NASDAQ:SNGX	Soligenix Inc
2024/05/23	20:30	PR Newswire (US)	Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split	NASDAQ:SNGX	Soligenix Inc
2024/05/23	05:05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SNGX	Soligenix Inc
2024/05/22	01:35	GlobeNewswire Inc.	PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon	NASDAQ:SNGX	Soligenix Inc
2024/05/21	20:30	PR Newswire (US)	SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference	NASDAQ:SNGX	Soligenix Inc
2024/05/20	20:30	PR Newswire (US)	Soligenix Encourages Stockholders to Vote Prior to Annual Meeting	NASDAQ:SNGX	Soligenix Inc
2024/05/18	05:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNGX	Soligenix Inc
2024/05/18	05:09	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SNGX	Soligenix Inc
2024/05/16	20:30	PR Newswire (US)	Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice	NASDAQ:SNGX	Soligenix Inc
2024/05/16	05:05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SNGX	Soligenix Inc
2024/05/11	05:16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SNGX	Soligenix Inc
2024/05/11	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNGX	Soligenix Inc
2024/05/10	20:30	PR Newswire (US)	Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results	NASDAQ:SNGX	Soligenix Inc
2024/05/06	20:30	PR Newswire (US)	Soligenix to Present at Upcoming Conferences	NASDAQ:SNGX	Soligenix Inc
2024/04/25	20:30	PR Newswire (US)	Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa	NASDAQ:SNGX	Soligenix Inc
2024/04/18	21:30	PR Newswire (US)	Soligenix Announces Pricing of $4.75 Million Public Offering	NASDAQ:SNGX	Soligenix Inc
2024/04/15	20:30	PR Newswire (US)	FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection	NASDAQ:SNGX	Soligenix Inc
2024/04/11	20:30	PR Newswire (US)	FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection	NASDAQ:SNGX	Soligenix Inc
2024/04/03	20:30	PR Newswire (US)	Soligenix Announces Agreement on the Design of a Second Confirmatory Placebo-Controlled Trial for HyBryte™ With the European Medicines Agency	NASDAQ:SNGX	Soligenix Inc
2024/03/15	20:30	PR Newswire (US)	Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results	NASDAQ:SNGX	Soligenix Inc
2024/02/08	21:30	PR Newswire (US)	Soligenix Announces Formation of Behçet's Disease Medical Advisory Board	NASDAQ:SNGX	Soligenix Inc
2024/01/25	21:30	PR Newswire (US)	Soligenix to Present at The Microcap Conference	NASDAQ:SNGX	Soligenix Inc
2024/01/08	21:30	PR Newswire (US)	FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease	NASDAQ:SNGX	Soligenix Inc
2024/01/04	21:30	PR Newswire (US)	Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis	NASDAQ:SNGX	Soligenix Inc
2024/01/02	21:30	PR Newswire (US)	Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses	NASDAQ:SNGX	Soligenix Inc
2023/12/23	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNGX	Soligenix Inc
2023/12/18	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SNGX	Soligenix Inc
2023/12/16	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SNGX	Soligenix Inc
2023/12/16	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SNGX	Soligenix Inc

검색 관련기사 보기:NASDAQ:SNGX

1 2 3 4 5 6 7 8 9 10 다음 >>

SPDR Portfolio Europe ETF

In School Portfolio Clas...

BBSEF272 Ex:27,25

Wt Palladi 1x S

ETFS Short JPY Long EUR

Long Harbour Exploration Corp.

Moury Construct

Stanley Furniture (QB)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관